Name | ONKODIAGNOSTIKA ATLAS, OOO |
|---|
INN | 5408287687 |
|---|
KPP | 770601001 |
|---|
OGRN | 1115476059401 |
|---|
OKPO | 91709359 |
|---|
Address | 119049, G.MOSKVA, pr-kt. Leninskiy, d. 4, pomesch. 2/2 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 21.20.2 | Additional activity | Production of materials used in medical applications | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 74.20 | Additional activity | Interior Design and Interior Design | | 74.30 | Additional activity | Translation and interpretation activities | | 82.92 | Additional activity | Activities of packing goods | | 86 | Additional activity | Health service | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 17.05.2011 |
|---|
Registering department | Mezhrayonnaya inspektsiya FNS Rossii 16 po Novosibirskoy oblasti |
|---|
|
ONKOATLAS, OOO (Novosibirsk Oblast; INN 5408287687) was registered on 17 May 2011. The company's authorized capital as of July 1, 2012 was 11579 rub. Type of ownership of ONKOATLAS, OOO - Limited liability companies. Form of ownership of ONKOATLAS, OOO - Private property. Principal activities of ONKOATLAS, OOO: research and experimental development on natural sciences and engineering other (72.19), production of materials used in medical applications (21.20.2), wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of ONKOATLAS, OOO made up 20.18 million RUB over 2023 compared to net loss of 6.30 million RUB over 2022, the company informed. Revenue increased in the accounting period 1.57 times to 182.87 million RUB from 116.32 million RUB over 2022; cost of goods sold grew by 31.09% to 78.48 million RUB from 59.87 million RUB; sales profit made up 31.46 million RUB compared to sales loss of 18.90 million RUB. 2022
Net loss (RAS) of ONKOATLAS, OOO dropped over 2022 by 33.82% to 6.30 million RUB from 9.51 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.59 times to 116.32 million RUB from 73.28 million RUB over 2021; cost of goods sold grew 1.74 times to 59.87 million RUB from 34.40 million RUB; sales loss decreased by 18.58% to 18.90 million RUB from 23.21 million RUB. 2021
Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO increased 3.80 times to 9.51 million RUB from 2.50 million RUB over 2020, the company informed. Revenue increased in the accounting period 2.06 times to 73.28 million RUB from 35.57 million RUB over 2020. 2020
Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO dropped over 2020 3.78 times to 2.50 million RUB from 9.45 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.50 times to 35.57 million RUB from 23.70 million RUB over 2019. 2018
Net loss (RAS) of ONKODIAGNOSTIKA ATLAS, OOO increased 1.89 times to 5.49 million RUB from 2.90 million RUB over 2017, the company informed. Revenue increased in the accounting period 1.78 times to 11.04 million RUB from 6.21 million RUB over 2017; cost of goods sold grew 1.85 times to 16.82 million RUB from 9.10 million RUB; sales loss grew 2.00 times to 5.78 million RUB from 2.89 million RUB. 2017
Net loss (RA) of ONKODIAGNOSTIKA ATLAS, OOO made up 2.90 million RUB over 2017 compared to net profit of 259.00 thousand RUB over 2016, the company informed. Revenue decreased in the accounting period by 7.95% to 6.21 million RUB from 6.75 million RUB in 2016; cost of goods sold grew by 41.15% to 9.10 million RUB from 6.45 million RUB; sales loss made up 2.89 million RUB compared to sales profit of 304.00 thousand RUB. 2016
Net profit (RAS) of ONKODIAGNOSTIKA ATLAS, OOO made up 259.00 thousand RUB over 2016 compared to net loss of 1.45 million RUB over 2015, the company informed. Revenue increased in the accounting period 9.64 times to 6.75 million RUB from 700.00 thousand RUB over 2015; cost of goods sold grew 3.06 times to 6.45 million RUB from 2.11 million RUB; sales profit made up 304.00 thousand RUB compared to sales loss of 1.41 million RUB. 2014
Net profit (RAS) of TSSB Genomika, OOO made up 2.10 million RUB over 2014 compared to net loss of 18.00 thousand RUB over 2013, the company informed. 2013
Net loss (RA) of TSSB Genomika, OOO made up 18.00 thousand RUB over 2013 compared to net profit of 228.00 thousand RUB over 2012, the company informed. Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 270.00 thousand RUB in 2012; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 40.00 thousand RUB; sales profit made up 0 RUB compared to 230.00 thousand RUB. 2012
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|